James Cavanaugh - Nov 13, 2024 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Director
Signature
/s/ Douglas E. Onsi, as attorney-in-fact for James Cavanaugh
Stock symbol
LPTX
Transactions as of
Nov 13, 2024
Transactions value $
$601
Form type
4
Date filed
11/15/2024, 05:31 PM
Previous filing
Oct 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LPTX Common Stock Exercise of in-the-money or at-the-money derivative security $601 +213 $2.82 213 Nov 13, 2024 Direct F1
holding LPTX Common Stock 262K Nov 13, 2024 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Warrant (Right to Buy) Exercise of in-the-money or at-the-money derivative security $0 -213 -100% $0.00 0 Nov 13, 2024 Common Stock, $0.001 par value per share 213 $2.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 13, 2024, James Cavanaugh exercised a warrant to purchase 213 shares of the Issuer's common stock at an exercise price of $2.82 per share.
F2 These shares are held by the HCV VIII Trust (the "HCV Trust"). The reporting person is a beneficiary of the HCV Trust and may be deemed to have beneficial ownership of the 261,840 shares of Common Stock held by the HCV Trust. The reporting person disclaims beneficial ownership of such shares of Common Stock held by the HCV Trust, except to the extent of the reporting person's proportionate pecuniary interest in such shares of Common Stock.